Jazz Pharmaceuticals PLC JAZZ:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
133.22UNCH (UNCH)
Volume
188,943
Close
133.22quote price arrow up+1.48 (+1.12%)
Volume
1,025,190
52 week range
127.83 - 189.00
Loading...
  • Open131.50
  • Day High134.58
  • Day Low131.32
  • Prev Close131.74
  • 52 Week High189.00
  • 52 Week High Date06/15/21
  • 52 Week Low127.83
  • 52 Week Low Date09/16/21

Key Stats

  • Market Cap8.174B
  • Shares Out61.36M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change-19.29

KEY STATS

  • Open131.50
  • Day High134.58
  • Day Low131.32
  • Prev Close131.74
  • 52 Week High189.00
  • 52 Week High Date06/15/21
  • 52 Week Low127.83
  • 52 Week Low Date09/16/21
  • Market Cap8.174B
  • Shares Out61.36M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change-19.29

RATIOS/PROFITABILITY

  • EPS (TTM)0.94
  • P/E (TTM)141.09
  • Fwd P/E (NTM)9.14
  • EBITDA (MRQ)825.629M
  • ROE (MRQ)1.10%
  • Revenue (MRQ)2.626B
  • Gross Margin (MRQ)90.42%
  • Net Margin (MRQ)1.37%
  • Debt To Equity (MRQ)163.24%

EVENTS

  • Earnings Date11/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Jazz Pharmaceuticals PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead marketed products include Xyrem (sodium oxybate oral solution) for the treatment of both cataplexy and excessive daytime sleepiness in patients with...
Bruce Cozadd
Chairman
Daniel Swisher Jr.
President
Christopher Tovey
Chief Operating Officer
Renee Gala
Chief Financial Officer
Patricia Carr
Chief Accounting Officer
Kimberly Sablich
Executive Vice President
Address
Fifth Fl
Waterloo Exchange, Waterloo Road
Dublin
4
Ireland